GE HealthCare CFO reports tax withholding of 3,238 shares

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro reported two tax-withholding dispositions of common stock on September 1, 2025, when shares were withheld to cover taxes upon vesting of restricted stock units.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro reported two tax-withholding dispositions of common stock on September 1, 2025, when shares were withheld to cover taxes upon vesting of restricted stock units. In total, 3,238 shares were withheld at $73.73 per share. After these transactions, he directly holds 58,594 shares of common stock.

Insights

Financial Analyst

TL;DR: Routine tax-withholding dispositions by the CFO on RSU vesting; informational, not materially market-moving.

The report documents two small disposals totaling 3,238 shares via withholding to satisfy tax obligations at a price of $73.73 per share on 09/01/2025. Such transactions are standard when restricted stock units vest and do not represent open-market selling pressure by the executive. The remaining beneficial ownership figures are disclosed for completeness. There is no indication of additional compensatory or unusual arrangements in the filing.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 reporting; transaction coded correctly as tax withholding on RSU vesting.

The Form 4 identifies the reporting person as the CFO and uses transaction code F, consistent with share withholding to cover tax liabilities on vested equity. The filing includes required post-transaction beneficial ownership counts and was signed by an authorized attorney-in-fact. From a governance and compliance perspective, the submission appears routine and complete based on the information provided.

Insider Trade Summary

Exercise Price or Tax Liability: 3,238 shares

Exercise Price or Tax Liability 2 txns

Insider SACCARO JAMES

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	1,740	$73.73	$128K
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	1,498	$73.73	$110K

Holdings After Transaction: Common Stock, par value $0.01 per share — 58,594 shares (Direct)

Footnotes (1)

1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Key Figures

Total shares withheld for taxes: 3,238 shares First withholding transaction: 1,740 shares at $73.73 per share Second withholding transaction: 1,498 shares at $73.73 per share +2 more

5 metrics

Total shares withheld for taxes 3,238 shares Tax-withholding dispositions on September 1, 2025 in connection with RSU vesting

First withholding transaction 1,740 shares at $73.73 per share Common stock withheld to satisfy tax obligations

Second withholding transaction 1,498 shares at $73.73 per share Additional common stock withheld for tax obligations

Post-transaction holdings 58,594 shares Direct common stock holdings of CFO James Saccaro after tax withholding

Per-share value used $73.73 per share Applied to both tax-withholding dispositions on GE HealthCare common stock

Key Terms

restricted stock units, tax withholding obligations, par value $0.01 per share

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"common stock to satisfy tax withholding obligations in connection"

par value $0.01 per share financial

"Common Stock, par value $0.01 per share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GEHC's CFO James Saccaro report?

James Saccaro reported two tax-withholding dispositions of GE HealthCare common stock. On September 1, 2025, a total of 3,238 shares were withheld to satisfy tax obligations tied to the vesting of restricted stock units, rather than being sold in the open market.

How many GEHC shares were withheld for taxes in James Saccaro's Form 4?

The filing shows 3,238 shares of GE HealthCare common stock withheld for tax obligations. These include separate withholdings of 1,740 shares and 1,498 shares, each at a price of $73.73 per share, in connection with restricted stock unit vesting.

At what price were GEHC shares valued in James Saccaro's tax withholding?

Both tax-withholding transactions used a $73.73 per share value for GE HealthCare common stock. This price was applied to 1,740 shares and 1,498 shares, respectively, when shares were delivered to satisfy tax withholding obligations on vested restricted stock units.

How many GEHC shares does CFO James Saccaro hold after these transactions?

After the reported tax-withholding dispositions, James Saccaro directly holds 58,594 shares of GE HealthCare common stock. This post-transaction balance reflects his remaining ownership following the withholding of 3,238 shares for tax obligations on restricted stock unit vesting.

Were James Saccaro's GEHC transactions stock sales or tax withholdings?

The transactions were tax-withholding dispositions, not open-market stock sales. Code F and the footnote explain that GE HealthCare shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units granted to James Saccaro.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACCARO JAMES

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		1,740(1)	D	$73.73	60,092	D
Common Stock, par value $0.01 per share	09/01/2025		F		1,498(1)	D	$73.73	58,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.